CD8A and myeloid sarcoma: Freshly isolated CD8+ T cells from 26 consecutive HLA-A2+ patients with MS (Table 1) and 27 HDs were tested for the capacity to form IFN-γ spots in an ELISPOT assay within 4 to 6 h of contact either with 12 pools containing a total of 90 synthetic HLA-A2-binding apoptotic peptides (Additional file 1: Table S1) [25,29,35], or with overlapping peptides spanning the entire sequence of the MBP (Additional file 1: Table S2) [28].